Caroline Ruiz

Ms. Ruiz was appointed Vice President of Clinical Operations in January 2022. She joined MEI as Executive Director of Clinical Operations in July 2020. She has over 20 years of experience in drug development across multiple indications, including oncology, the central nervous system, and immunology. She has held various senior positions in Clinical Management and Clinical Operations, managing regional business units, large portfolios (40+ studies), and global teams. Previously, she was Senior Director, Neurodegenerative Disease Portfolio Head, at IQVIA. She received a bachelor’s degree in Biology from University of California, San Diego.